April 29, 2020 / 5:39 PM / in a month

BRIEF-OPKO Health's Bioreference Labs In Partnership With New York State Initiates Testing For COVID-19 Antibodies

April 29 (Reuters) -

* OPKO HEALTH’S BIOREFERENCE LABORATORIES IN PARTNERSHIP WITH NEW YORK STATE INITIATES TESTING FOR COVID-19 ANTIBODIES

* BIOREFERENCE LABORATORIES - BEGINNING TODAY, WILL OFFER ANTIBODY BLOOD TESTS TO DETECT IMMUNE RESPONSE AFTER INFECTION WITH COVID-19 VIRUS

* BIOREFERENCE LABORATORIES - TO OFFER ANTIBODY BLOOD TESTS TO DETECT IMMUNE RESPONSE AFTER INFECTION WITH COVID-19 VIRUS

* BIOREFERENCE LABORATORIES - WORKING EXPEDITIOUSLY TO BE ABLE TO TEST 400,000 PATIENTS PER DAY BY MID-MAY.

* BIOREFERENCE LABORATORIES - THIS WEEK, CO LAUNCHES COVID-19 ANTIBODY TESTING NATIONWIDE

* BIOREFERENCE LABORATORIES - WORKING EXPEDITIOUSLY TO BE ABLE TO TEST 400,000 PATIENTS PER DAY BY MID-MAY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below